Jay Bryant to Pixels & Pills: Pharma brand marketing on Facebook is a manageable risk
Pixels & Pills interviews LiveWorld Sales VP Jay Bryant about how pharma companies are marketing and communicating through social media.
(more...)Adverse events only small percentage of comments on pharma Facebook Pages
LiveWorld analyzed 5 pharma Facebook Pages over a 3-month period and found that less than 2 percent of fan comments mentioned adverse events. See the rest of our findings.
(more...)Presentation on Facebook pharma changes
Changes are coming to Facebook that will require pharma companies to allow fan comments on their Wall posts. And in the presentation, LiveWorld Chief Community Officer Jenna Woodul shares how pharma marketers should prepare for this new two-way environment.
(more...)Getting ready for Facebook pharma changes
LiveWorld view of how pharma companies need to prepare for changes to the rules about public commenting on Facebook Pages.
(more...)LiveWorld submission to the FDA on social media in healthcare
The highlights of LiveWorld’s submission to the Food and Drug Administration (FDA) around best practices in social media for healthcare and pharmaceutical companies.
(more...)